LLY

745.95

-1.14%↓

JNJ

177.42

-0.37%↓

ABBV

214.73

-1.64%↓

UNH

348.54

-1.24%↓

AZN

77.58

-2.46%↓

LLY

745.95

-1.14%↓

JNJ

177.42

-0.37%↓

ABBV

214.73

-1.64%↓

UNH

348.54

-1.24%↓

AZN

77.58

-2.46%↓

LLY

745.95

-1.14%↓

JNJ

177.42

-0.37%↓

ABBV

214.73

-1.64%↓

UNH

348.54

-1.24%↓

AZN

77.58

-2.46%↓

LLY

745.95

-1.14%↓

JNJ

177.42

-0.37%↓

ABBV

214.73

-1.64%↓

UNH

348.54

-1.24%↓

AZN

77.58

-2.46%↓

LLY

745.95

-1.14%↓

JNJ

177.42

-0.37%↓

ABBV

214.73

-1.64%↓

UNH

348.54

-1.24%↓

AZN

77.58

-2.46%↓

Search

West Pharmaceutical Services Inc

Open

SectorHealthcare

257.09 1.38

Overview

Share price change

24h

Current

Min

252.36

Max

257.88

Key metrics

By Trading Economics

Income

42M

132M

Sales

68M

766M

P/E

Sector Avg

37.897

35.664

EPS

1.45

Dividend yield

0.33

Profit margin

17.202

Employees

10,600

EBITDA

48M

199M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+25.89% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.33%

3.12%

Next Earnings

23 Oct 2025

Next Dividend date

19 Nov 2025

Next Ex Dividend date

12 Nov 2025

Market Stats

By TradingEconomics

Market Cap

3.1B

18B

Previous open

255.71

Previous close

257.09

News Sentiment

By Acuity

50%

50%

148 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Sept 2025, 22:41 UTC

Major Market Movers

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

12 Sept 2025, 16:04 UTC

Major Market Movers

Upexi Shares Climb on Solana Gains

14 Sept 2025, 23:48 UTC

Market Talk

Oil Futures Mixed Amid Divergent Signals -- Market Talk

14 Sept 2025, 23:41 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

14 Sept 2025, 23:38 UTC

Market Talk

China's Economic Activity Data May Continue Reflecting Slowdown -- Market Talk

14 Sept 2025, 23:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 Sept 2025, 23:13 UTC

Market Talk

Global Energy Roundup: Market Talk

14 Sept 2025, 23:13 UTC

Market Talk

Infratil May Need to Be More Aggressive With Asset Sales -- Market Talk

14 Sept 2025, 23:13 UTC

Market Talk

Global Equities Roundup: Market Talk

14 Sept 2025, 23:04 UTC

Market Talk

Aristocrat's Interactive Unit Appears in Safe Hands -- Market Talk

13 Sept 2025, 08:20 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

12 Sept 2025, 20:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

12 Sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 Sept 2025, 20:09 UTC

Earnings

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

12 Sept 2025, 19:23 UTC

Market Talk

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 Sept 2025, 19:16 UTC

Market Talk

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 Sept 2025, 19:03 UTC

Market Talk

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

12 Sept 2025, 18:59 UTC

Market Talk

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

12 Sept 2025, 18:38 UTC

Market Talk
Earnings

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

12 Sept 2025, 18:33 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

12 Sept 2025, 18:22 UTC

Market Talk

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

12 Sept 2025, 16:56 UTC

Market Talk

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

12 Sept 2025, 16:22 UTC

Earnings

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

12 Sept 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 Sept 2025, 16:19 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12 Sept 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

12 Sept 2025, 16:11 UTC

Earnings

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

12 Sept 2025, 15:37 UTC

Market Talk

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

12 Sept 2025, 15:22 UTC

Market Talk

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

12 Sept 2025, 15:07 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

Peer Comparison

Price change

West Pharmaceutical Services Inc Forecast

Price Target

By TipRanks

25.89% upside

12 Months Forecast

Average 319.13 USD  25.89%

High 350 USD

Low 245 USD

Based on 9 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

213.26 / 219.27Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

148 / 371 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat